Product Images Meclofenamate Sodium

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Meclofenamate Sodium NDC 0378-3000 by Mylan Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Meclofenamate Sodium Capsules, USP 50 mg Bottle Label - image 01

Meclofenamate Sodium Capsules, USP 50 mg Bottle Label - image 01

Meclofenamate Sodium Capsules, USP 100 mg Bottle Label - image 02

Meclofenamate Sodium Capsules, USP 100 mg Bottle Label - image 02

Scattergram of Menstrual Flow Average of Two Periods on Each Treatment of 55 Women from Three Clinical Trials - image 03

Scattergram of Menstrual Flow Average of Two Periods on Each Treatment of 55 Women from Three Clinical Trials - image 03

This appears to be a prescription medication called Meclofenamate Sodium, USP monohydrate, which is available in capsule form. The usual dosage is between 200 and 400 mg. The medication should be stored in a cool, dry place away from light, in a tightly sealed, light-resistant container. The accompanying Medication Guide should be given to each patient by the pharmacist. There is additional information on the packaging related to proper storage and handling of the medication.*

Meclofenamate Structural Formula - image 04

Meclofenamate Structural Formula - image 04

Each capsule of Meclofenamate Sodium Capsules, USP contains 100 mg of meclofenamate acid. The usual recommended dosage is 200 to 400 mg per day, split into three or four equal doses. Full prescribing information can be found in the package insert. This medication should be kept out of the reach of children, stored between 20° and 26°C (68°F and 77°F) in a controlled room temperature environment and away from light and moisture. It should be dispensed in a tightly closed, light-resistant container with child-resistant closure. The code NHIDRUES/25/NKD/BY should be used for dispensing purposes. The text suggests that Mylan Pharmaceuticals Inc. produced this medication, and it was made in India. The GTIN is 000000000000, and the lot number is X000, with an expiry date of MM YYYY. If you are dispensing this medication, it is essential to provide the accompanying medication guide to the patient.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.